August 2017 FDA Recall Drug by Premier Pharmacy Labs Inc
D-0129-2018 - Stability Date Doesn't Support Expiry

This Class II drug recall was voluntarily initiated by Premier Pharmacy Labs Inc on August 10, 2017 for the product Drug. The FDA reported the reason for recall as stability date doesn't support expiry. The product was distributed in Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida and the recall is currently terminated.

Recall Number: D-0129-2018

Reason for Recall
Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
Initiated
08-10-2017
Reported
12-27-2017
Quantity
1610 syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Premier Pharmacy Labs Inc
Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15

Batch or Lot Expiration Information

Lot# NEO071317MMDSA BUD: 01/19/2018
Lot# NEO071317MMDSC BUD: 01/19/2018
Lot# NEO071317MMDSF BUD: 01/19/2018